|Usage:||Professional Use||Shelf Life:||24 Months|
Opiate Rapid Test Kit,
OPI Rapid Test Kit,
Opiate Rapid Test Cassette
Opiate (OPI) Rapid Test Kit Drug of Abuse Rapid Test Cassette for Urine Sample
Opiate (OPI) Rapid Test is a rapid, screening testfor the qualitative detection of Opiate and metabolites in human urine at specified cut oflevels.
For professional use only.
For in vitro diagnostic use only.
Opiate (OPI) Rapid Test is an immuno-chromatographic assay for the qualitative determination of the presence of Opiate 2000 (OPI) listed in the table below.
|Opiate 2000 (OPI)||Morphine||2000ng/mL|
This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to Opiate 2000 (OPI) of abuse test result, particularly when preliminary positive results are indicated.
Opiate (OPI) Rapid Test is a rapid yields a positive result when the concentration of Opiates in urine exceeds 2000ng/mL.
Opiate (OPI) Rapid Test is a competitive immunoassay that is used to screen for the presence of various Opiate 2000 (OPI) and metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into test by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test . This produces a colored Test line in the Test Region (T) of the Test, which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C) of Test, if the test has been performed properly.
【WARNINGS AND PRECAUTIONS】
【STORAGE AND STABILITY】
【INTERPRETATION OF RESULTS】
Preliminary positive (+)
Only one colored band appears, in the control region (C). No colored band appears in the test region (T).
Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).
Control band fails to appear. Results from any test which has not produced a control band at the specified read time must be discarded. Please review the procedure and repeat with a new test. If the problem persists, discontinue using the kit immediately and contact your local distributor.